ArticleTransboundary and emerging diseases2019
Systemic resilience to cross-border infectious disease threat events in Europe.
Article in Transboundary and emerging diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- The Concept and Scope of Resilience Against Infectious Disease Outbreaks.China CDC weekly · 2025Article
- Why do International Health Regulations self-assessment capacities (SPAR) scores not predict COVID-19 control outcomes? - analysis of the relationship between SPAR scores and COVID-19 resilience scores in 2021.Globalization and health · 2025Article
- Environmental effects of surgical procedures and strategies for sustainable surgery.Nature reviews. Gastroenterology & hepatology · 2023Review
- Does the Public Health Security Capacity Provide Better Preparedness for Health Emergencies? A Cross-Sectional Analysis of 180 Countries During the COVID-19 Outbreak.Disaster medicine and public health preparedness · 2022Article
- Analyzing self-evaluation capacity scores related to infectious disease control in International Health Regulations during the first year of COVID-19 pandemic.Scientific reports · 2022Article
- Climate change and infectious disease in Europe: Impact, projection and adaptation.The Lancet regional health. Europe · 2021Review
- The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.Lancet (London, England) · 2021Article
- Cascading risks of waterborne diseases from climate change.Nature immunology · 2020Article
- Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries.Lancet (London, England) · 2020Article
- Article
- Systemic resilience to cross-border infectious disease threat events in Europe.Transboundary and emerging diseases · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent health emergencies threaten global health security. International Health Regulations (IHR) aim to prevent, detect and respond to such threats, through increase in national public health core capacities, but whether IHR core capacity implementation is necessary and sufficient has been contested. With a longitudinal study we relate changes in national IHR core capacities to changes in cross-border infectious disease threat events (IDTE) between 2010 and 2016, collected through epidemic intelligence at the European Centre for Disease Prevention and Control (ECDC). By combining all IHR core capacities into one composite measure we found that a 10% increase in the mean of this composite IHR core capacity to be associated with a 19% decrease (p = 0.017) in the incidence of cross-border IDTE in the EU. With respect to specific IHR core capacities, an individual increase in national legislation, policy & financing; coordination and communication with relevant sectors; surveillance; response; preparedness; risk communication; human resource capacity; or laboratory capacity was associated with a significant decrease in cross-border IDTE incidence. In contrast, our analysis showed that IHR core capacities relating to point-of-entry, zoonotic events or food safety were not associated with IDTE in the EU. Due to high internal correlations between core capacities, we conducted a principal component analysis which confirmed a 20% decrease in risk of IDTE for every 10% increase in the core capacity score (95% CI: 0.73, 0.88). Globally (EU excluded), a 10% increase in the mean of all IHR core capacities combined was associated with a 14% decrease (p = 0.077) in cross-border IDTE incidence. We provide quantitative evidence that improvements in IHR core capacities at country-level are associated with fewer cross-border IDTE in the EU, which may also hold true for other parts of the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.